Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio 
How Braden Business Systems Use Auvik SaaS Management
to Identify, Secure, and Manage SaaS Sprawl About Braden Business Systems & Jon Fitzryk Since 1989, Braden Business Systems has...
Efficient Network Management: A Dive into Auvik Network Management’s Robust Features
In today's fast-paced digital world, efficient and effective network management has become more important than ever. With businesses relying heavily...
Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
Organon to Present New Research on Access and Value at ISPOR 2026
New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolioJERSEY CITY,...
Imperative Care Appoints Jay Martin as Chief Commercial Officer
Seasoned medtech executive Jay Martin to lead commercial organization as Imperative Care scales across stroke and vascular marketsCAMPBELL, Calif.--(BUSINESS WIRE)--Imperative...
Glidewell TV Celebrates One Year of On-Demand Dental Education
Continued Content Expansion Strengthens Streaming Service Dedicated to Dental Education and Practice Growth IRVINE, CA / ACCESS Newswire / May...
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
Will Add Two Independent Directors with MedTech and Operations Experience to be Named at a Later Date Reconstituted Operations and...
Netsmart Announces Innovator and Adoption Impact Award Recipients for Healthcare IT Value Model
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#CareAdministration--Netsmart, an industry-leading technology platform company with a suite of solutions and services, announces the recipients of...
CVS Health’s Annual Impact in Rhode Island
Originally published in the CVS Health National Economic Impact Report WOONSOCKET, RI / ACCESS Newswire / May 15, 2026 /...
EHDS Readiness Shifts from EU Policy to Provider Budget and Vendor Accountability
Black Book Research's Pre-HIMSS26 Europe study of 881 healthcare leaders across 14 countries finds European Health Data Space readiness is...
NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical...
NanoViricides, Inc. Has Filed its Quarterly Report – NV-387 Advancing for Phase II
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has...
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
Entering a Transformative Stage by Advancing PRP to a Pivotal, Phase 1b, FIH, Clinical Study Whilst Undertaking Additional Research into...
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing...
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
Federal Officials, Researchers, Clinicians and Biopharma Leadership Convened by Psychedelic Medicine Coalition at the National Press Club Vancouver, Canada, May...
CytoDyn to Present at the LD Micro Invitational XVI
CFO Robert E. Hoffman to deliver company presentation on May 18 at 10 a.m. PT VANCOUVER, Washington, May 15, 2026...
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in...
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”),...
Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial
Early blinded results show 40% composite complete remission rate across difficult-to-treat AML patient population in MIRACLE Trial First interim unblinding...
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and...
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and...
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results
SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",...